Dopamine–prolactin pathway potentially contributes to the schizophrenia and type 2 diabetes comorbidity

C. Gragnoli, G. M. Reeves, J. Reazer, T. T. Postolache

Research output: Contribution to journalReview article

11 Scopus citations

Fingerprint Dive into the research topics of 'Dopamine–prolactin pathway potentially contributes to the schizophrenia and type 2 diabetes comorbidity'. Together they form a unique fingerprint.

Medicine & Life Sciences